Page last updated: 2024-09-04

temiverine and Glioblastoma

temiverine has been researched along with Glioblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chandrika, G; Chugh, A; Natesh, K; Ranade, D; Shastry, P	1

Other Studies

1 other study(ies) available for temiverine and Glioblastoma

Article	Year
Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling. Scientific reports, 2016, Mar-04, Volume: 6 Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Glioblastoma; Humans; Indoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Naphthyridines; Neoplasm Invasiveness; NF-kappa B; Phenylacetates; Protein Kinase C-alpha; Purines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2016

Article

Year

Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling.

Scientific reports, 2016, Mar-04, Volume: 6

Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Glioblastoma; Humans; Indoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Naphthyridines; Neoplasm Invasiveness; NF-kappa B; Phenylacetates; Protein Kinase C-alpha; Purines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2016